Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
- Resource Type
- Source
- European Journal of Cancer.
- Subject
Cancer Research Oncology - Language
- ISSN
- 0959-8049